Roche NimbleGen
Chemistry custom R&D for biochip applications, novel chemistries for use in nucleic acid and protein arrays
NimbleGen Systems was acquired by Roche in 2007.
NimbleGen Systems Inc.
1 Science Court
Madison, WI 53711
Tel: (608) 218-7600
Fax: (608) 218-7601
The company’s Maskless Array Synthesis (MAS) technology uses digital light processing and rapid, high-yield photochemistry to synthesise long oligo, high-density DNA microarrays with extreme flexibility.
Related patents
Related news
- Roche NimbleGen and Sigma-Aldrich Collaborate to Advance Epigenetic Research
- Roche NimbleGen Microarray Technology Enables the Highest-Resolution Map of Human Genome Copy Number Variation
- Multiplex Gene Expression HD2 12x135K Microarrays Now Available from Roche NimbleGen
- Roche NimbleGen and BioDiscovery Form Strategic Alliance to Enhance CGH Microarrays, Software and Services
- Roche NimbleGen ENCODE Arrays: The Most Sensitive Platform for ChIP-chip Experiments
- Roche NimbleGen Launches NimbleGen Sequence Capture Technology for Targeted Genome Resequencing
- Affymetrix and Roche NimbleGen Expand Licensing Agreement
- Microarray Sequence Capture Speeds Large-Scale Resequencing
- NimbleGen Scientists Awarded Cancer Genome Atlas Grant for Technology Development.
- NimbleGen Microarrays Used as Primary Platform for ChIP-chip Discovery in ENCODE Project
- Nimblegen Systems, Inc. Adds DNA Methylation Arrays and Services to Growing Product Portfolio
- Gregg Fergus Joins NimbleGen Systems' Board of Directors
- Nimblegen Systems, Inc. Files for Initial Public Offering
- Leroy Hood Joins NimbleGen's Scientific Advisory Board
- Oxford Gene Technology and NimbleGen Systems, Inc. Enter into Licensing and Supply Agreement
- Gregory McGuinness Appointed VP of International Business at NimbleGen Systems, Inc.
- Novel Experiment Documents Evolution of Genome in Near-Real Time
- NimbleGen’s High-Resolution Array CGH Pinpoints - Location of Genomic Aberrations Causing Mental Retardation
- David S. Snyder Appointed CFO of NimbleGen Systems, Inc.
- NimbleGen Announces Limited Access Program for NimbleChip HD2 Chromatin Immunoprecipitation (ChIP) Arrays
- Jivan and NimbleGen Partner for Splice Array Market
